杰弗里·r·斯图尔特

Executive Vice President, Chief Commercial Officer

\n"}}" id="text-89dcf61c47" class="cmp-text">

执行副总裁,首席商务官

Jeffrey R. Stewart is Executive Vice President, Chief Commercial Officer. He is responsible for leading the global commercial organization for the enterprise.

\r\n

Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former U.S. joint venture with Takeda Chemical Industries. Following his time with TAP, Mr. Stewart held various leadership positions in Abbott’s U.S. and international pharmaceutical businesses, including Divisional Vice President, Immunology; Divisional Vice President, Primary Care; General Manager, Virology; and General Manager, United Kingdom. Prior to AbbVie's separation from Abbott in January 2013, Mr. Stewart served as Vice President, Abbott Proprietary Pharmaceutical Division, United States.

\r\n

Mr. Stewart previously led the U.S. Area for 10 years, including most recently as Senior Vice President, U.S. Commercial Operations.
\r\n

\r\n

Mr. Stewart previously served on the Board of the National Pharmaceutical Council. At AbbVie, he is the executive chair of the PRIDE Employee Resource Group.

\r\n"}}" id="text-11d8864ed5" class="cmp-text">

杰弗里·r·斯图尔特是执行副总裁,首席商务官。他是负责领导企业的全球商业组织。

斯图尔特先生于1992年加入雅培作为开发的一部分,雅培是美国前与武田化学工业公司的合资企业。时间和利用后,Stewart先生举行各种领导职务雅培美国和国际的制药企业,包括部门副总裁免疫学;部门副总裁,初级保健;总经理,病毒学;英国和总经理。AbbVie分离前阿伯特2013年1月,Stewart先生担任副总裁,雅培专有制药部门,美国。

斯图尔特曾领导美国面积为10年,包括最近为高级副总裁,美国商业运作。

斯图尔特此前在全国医药委员会董事会。在AbbVie,他是骄傲的执行主席员工资源组。